title: Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa.
abstract: Macular edema (ME) in retinitis pigmentosa (RP) often impairs central vision dramatically. A 41-year-old woman diagnosed with RP was referred to our outpatient clinic due to severe visual deterioration in both eyes. The patient was treated with topical carbonic anhydrase inhibitors, topical corticosteroids and intravitreal triamcinolone acetonide injections, but her ME recurred. Intravitreal 0.7 mg dexamethasone implant (Ozurdex, Allergan) was administered into both eyes without complications. On the fourth day after both injections, visual acuity improved and ME almost totally resolved. No recurrence was observed at follow-up six months later.
authors.affiliation: Kırıkkale University Faculty of Medicine, Department of Ophthalmology, Kırıkkale, Turkey.
authors.forename: Nurgül
authors.initials: N
authors.lastname: Örnek
authors.affiliation: Kırıkkale University Faculty of Medicine, Department of Ophthalmology, Kırıkkale, Turkey.
authors.forename: Kemal
authors.initials: K
authors.lastname: Örnek
authors.affiliation: Kırıkkale University Faculty of Medicine, Department of Ophthalmology, Kırıkkale, Turkey.
authors.forename: İnci Elif
authors.initials: İE
authors.lastname: Erbahçeci
keywords: Macular edema; dexamethasone implant; retinitis pigmentosa